While the BRCA2 mutation is best known for its associated elevated breast and ovarian cancer risk, it also conveys an increased risk of pancreatic adenocarcinoma (PAC) as the most common genetic alteration found in familial pancreatic cancer. The gene discussed is BRCA2; the disease is familial pancreatic carcinoma.